MDR workshop on "denominator" data collection set for Sept. 17; industry speakers sought.
This article was originally published in The Gray Sheet
MANUFACTURER INPUT ON MDR "DENOMINATOR" DATA COLLECTION PROCEDURES is being sought by FDA from various segments of the medical device industry through a public workshop set for Sept. 17. FDA says it is looking for speakers who represent manufacturers of single use/disposable products, multiple use products, and implantables to discuss "methods they use to estimate" denominator data on the number of devices distributed per year and currently in use, according to an Aug. 16 Federal Register notice.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.